STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 99 filers reported holding STOKE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $104,528 | -57.6% | 26,530 | +14.5% | 0.00% | – |
| Q2 2023 | $246,265 | -74.2% | 23,167 | -79.8% | 0.00% | – |
| Q1 2023 | $954,000 | +433536.4% | 114,467 | +379.8% | 0.00% | – |
| Q4 2022 | $220 | -99.9% | 23,859 | +1.2% | 0.00% | – |
| Q3 2022 | $302,000 | +1.7% | 23,568 | +4.8% | 0.00% | – |
| Q2 2022 | $297,000 | -27.9% | 22,498 | +14.7% | 0.00% | – |
| Q1 2022 | $412,000 | +5.6% | 19,608 | +20.8% | 0.00% | – |
| Q4 2021 | $390,000 | +4.0% | 16,234 | +10.2% | 0.00% | – |
| Q3 2021 | $375,000 | -19.0% | 14,728 | +7.2% | 0.00% | – |
| Q2 2021 | $463,000 | +24.1% | 13,745 | +43.3% | 0.00% | – |
| Q1 2021 | $373,000 | 0.0% | 9,589 | +59.4% | 0.00% | – |
| Q4 2020 | $373,000 | +139.1% | 6,016 | +32.1% | 0.00% | – |
| Q3 2020 | $156,000 | +39.3% | 4,554 | -2.9% | 0.00% | – |
| Q2 2020 | $112,000 | -11.1% | 4,691 | -14.8% | 0.00% | – |
| Q1 2020 | $126,000 | +46.5% | 5,505 | +82.3% | 0.00% | – |
| Q4 2019 | $86,000 | +34.4% | 3,019 | +0.6% | 0.00% | – |
| Q3 2019 | $64,000 | – | 3,001 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $562,187,000 | 75.80% |
| RTW INVESTMENTS, LP | 3,544,248 | $118,697,000 | 2.86% |
| Cormorant Asset Management, LP | 1,537,807 | $51,501,000 | 1.98% |
| Redmile Group, LLC | 2,549,506 | $85,383,000 | 1.57% |
| Birchview Capital, LP | 40,000 | $1,340,000 | 0.45% |
| HighVista Strategies LLC | 17,082 | $572,000 | 0.42% |
| Perceptive Advisors | 671,978 | $22,505,000 | 0.33% |
| GILDER GAGNON HOWE & CO LLC | 1,490,153 | $49,905,000 | 0.31% |
| Artal Group S.A. | 270,750 | $9,067,000 | 0.22% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 323 | $11,000 | 0.20% |